Unknown PHASE4 INTERVENTIONAL 2-arm NCT03989024

Pulsatile Gonadotropin-releasing Hormone for Infertility in Non-obese Patients With Polycystic Ovary Syndrome

Sponsor: RenJi Hospital

Conditions Infertility Ovulation Disorder Polycystic Ovary Syndrome

Updated 5 times since 2019 Last updated: Jun 15, 2019 Started: Jul 1, 2019 Primary completion: Dec 30, 2020 Completion: Dec 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03989024, this PHASE4 trial focuses on Infertility and Ovulation Disorder and remains ongoing. Sponsored by RenJi Hospital, it has been updated 5 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2022 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jan 2022 [monthly]

Not Yet Recruiting PHASE4
Jul 2019 — Jan 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

RenJi Hospital

Data source: RenJi Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China